-
Je něco špatně v tomto záznamu ?
Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study
Marta Kalousová, Tomáš Krechler, Marie Jáchymová, Aleš A. Kuběna, Aleš Žák, Tomáš Zima
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9769
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-12-01 do 2015-12-31
Medline Complete (EBSCOhost)
od 2005-01-01 do 2016-12-31
Health & Medicine (ProQuest)
od 1997-12-01 do 2015-12-31
Public Health Database (ProQuest)
od 1997-12-01 do 2015-12-31
ROAD: Directory of Open Access Scholarly Resources
od 1987
- MeSH
- ferritiny krev MeSH
- lidé MeSH
- nádorové biomarkery krev MeSH
- nádory slinivky břišní krev mortalita patologie MeSH
- pilotní projekty MeSH
- prognóza MeSH
- ROC křivka MeSH
- staging nádorů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Prognosis of patients with pancreas cancer is very poor. The aim of the study was to test the significance of laboratory parameters in the prognosis of patients with pancreas cancer. The studied group included 57 patients (31 men, 26 women, mean age 65 ± 9 years). Blood was collected at the time of diagnosis of pancreas cancer and basic laboratory parameters, including nutritional and inflammatory markers and tumour markers were measured. Patients were followed up until death (median survival 147 days). Ferritin, iron, albumin, prealbumin, cholinesterase, haemoglobin, C-reactive protein, alkaline phosphatase and carcinoembryonic antigen were significant for patients' prognosis in univariate analysis while CA 19-9, bilirubin, liver, pancreas and kidney tests and lipids were not. Multivariate Cox regression demonstrated ferritin, iron and albumin as independent mortality predictors (RR (95%CI), per standard deviation: ferritin 1.497(1.215-2.241), p = 0.002; albumin, 0.716(0.521-0.977), p = 0.035; iron, 0.678(0.504-0.915), p = 0.010). Iron correlated significantly with albumin (r = 0.397, p = 0.002) but neither iron nor albumin correlated with ferritin. Patients who survived 100 days had significantly lower ferritin (median 239 μg/l vs. non-survivors 435 μg/l, p = 0.014), significantly higher albumin but the difference in serum iron was not quite significant. ROC analysis for ferritin revealed AUC for 100 days survival of 0.710, p = 0.007 (and 0.725, p = 0.004 for 200 days survival). AUC for albumin for 100 days survival was not significant (p = 0.073). This study points out ferritin as an independent mortality predictor in patients with pancreas cancer. High serum levels of ferritin at the time of diagnosis of pancreas cancer indicate bad prognosis of the patient.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000620
- 003
- CZ-PrNML
- 005
- 20170411113321.0
- 007
- ta
- 008
- 130108s2012 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13277-012-0426-z $2 doi
- 035 __
- $a (PubMed)22875781
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kalousová, Marta $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. marta.kalousova@seznam.cz
- 245 10
- $a Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study / $c Marta Kalousová, Tomáš Krechler, Marie Jáchymová, Aleš A. Kuběna, Aleš Žák, Tomáš Zima
- 520 9_
- $a Prognosis of patients with pancreas cancer is very poor. The aim of the study was to test the significance of laboratory parameters in the prognosis of patients with pancreas cancer. The studied group included 57 patients (31 men, 26 women, mean age 65 ± 9 years). Blood was collected at the time of diagnosis of pancreas cancer and basic laboratory parameters, including nutritional and inflammatory markers and tumour markers were measured. Patients were followed up until death (median survival 147 days). Ferritin, iron, albumin, prealbumin, cholinesterase, haemoglobin, C-reactive protein, alkaline phosphatase and carcinoembryonic antigen were significant for patients' prognosis in univariate analysis while CA 19-9, bilirubin, liver, pancreas and kidney tests and lipids were not. Multivariate Cox regression demonstrated ferritin, iron and albumin as independent mortality predictors (RR (95%CI), per standard deviation: ferritin 1.497(1.215-2.241), p = 0.002; albumin, 0.716(0.521-0.977), p = 0.035; iron, 0.678(0.504-0.915), p = 0.010). Iron correlated significantly with albumin (r = 0.397, p = 0.002) but neither iron nor albumin correlated with ferritin. Patients who survived 100 days had significantly lower ferritin (median 239 μg/l vs. non-survivors 435 μg/l, p = 0.014), significantly higher albumin but the difference in serum iron was not quite significant. ROC analysis for ferritin revealed AUC for 100 days survival of 0.710, p = 0.007 (and 0.725, p = 0.004 for 200 days survival). AUC for albumin for 100 days survival was not significant (p = 0.073). This study points out ferritin as an independent mortality predictor in patients with pancreas cancer. High serum levels of ferritin at the time of diagnosis of pancreas cancer indicate bad prognosis of the patient.
- 650 _2
- $a ferritiny $x krev $7 D005293
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a nádory slinivky břišní $x krev $x mortalita $x patologie $7 D010190
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a ROC křivka $7 D012372
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Krechler, Tomáš $u 4th Department of Medicine - Department of Gastroenterology and Hepatology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Jáchymová, Marie $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Kuběna, Aleš A. $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Žák, Aleš $u 4th Department of Medicine - Department of Gastroenterology and Hepatology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 33, č. 5 (2012), s. 1695-1700
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22875781 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20170411113620 $b ABA008
- 999 __
- $a ok $b bmc $g 963402 $s 798784
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 33 $c 5 $d 1695-1700 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
- GRA __
- $a NS9769 $p MZ0
- LZP __
- $a Pubmed-20130108